1st NASDAQ-traded company CEO Mike Gorenstein of Cronos Group and most pro-cannabis Republican, Congressman Dana Rohrabacher to address group; Dozens of Promising Cannabis Companies Pitch Investors in ‘Shark-Tank’ Style Format.

On the heels of Trump backing states’ rights on marijuana and former Speaker of the House John Boehner joining the cannabis industry, more than 200 high-net-worth investors from around the world will gather at The Westin Bayshore for a two-day forum on Tuesday, May 1st and Wednesday, May 2nd, hosted for members of The Arcview Investor Network. High net worth accredited investors will be reviewing pitches from companies who competed fiercely for a slot out of a field of hundreds of applicants. In 2017 alone, Arcview’s members placed more than $50 million in 60+ Arcview-curated companies, making them the top source of capital for the cannabis industry.

Mike Gorenstein, CEO of the Cronos Group, will deliver a keynote speech. Cronos, owner of numerous licensed cannabis producers in Canada, recently became the sector’s first company listed on a major U.S. exchange, and promptly raised $100 million. Congressman Dana Rohrabacher, the most pro-cannabis Republican in Congress and co-sponsor of the Rohrabacher–Farr amendment prohibiting the Justice Department from spending funds to interfere with the implementation of state medical cannabis laws, will also be addressing this group of industry leaders.

“In a few months, Canada will become the first G7 country to legalize cannabis. Investors have responded, pouring money into the sector and sending the stock prices of Canadian companies into the stratosphere. Now flush with cash, Canadian-listed companies are looking beyond the modestly-sized Canadian market for global opportunities, and turning their attention to the capital-constrained U.S. market. News of the President and top Republicans changing their tune on cannabis is adding to the excitement around the possibility of a rapid change in U.S. federal law,” said Troy Dayton, CEO and co-Founder of The Arcview Group.